**Question:** 2nd generation sulfonylurea drugs are all except:

A. Glyburide
B. Glimepiride
C. Tolbutamide
D. Glipizide

**Core Concept:**
Sulfonylurea drugs are a class of medications commonly used for the treatment of type 2 diabetes mellitus. They work by stimulating insulin release from the pancreas and improving insulin sensitivity in peripheral tissues. There are two main generations of sulfonylureas: first-generation agents and second-generation agents. First-generation sulfonylureas, like tolbutamide, are generally less potent, and second-generation sulfonylureas, like glyburide, glipizide, and glimepiride, are more potent and generally have a longer duration of action.

**Why the Correct Answer is Right:**
A first-generation sulfonylurea, tolbutamide, is excluded because it belongs to the older, less potent class of sulfonylureas.

**Why Each Wrong Option is Incorrect:**
A. Glyburide (also known as glibenclamide) is a second-generation sulfonylurea drug, so it cannot be the correct option.
B. Glimepiride (also known as amaryl) is another second-generation sulfonylurea drug, making it an incorrect choice.
C. Tolbutamide, as mentioned before, is a first-generation sulfonylurea drug and is excluded due to being less potent compared to second-generation drugs.
D. Glipizide (also known as minidiab or glybid) is a second-generation sulfonylurea drug, so it cannot be the correct option.

**Clinical Pearl:**
2nd generation sulfonylureas are generally considered more effective than first-generation sulfonylureas in terms of potency, duration of action, and overall efficacy in treating type 2 diabetes mellitus. Their longer duration of action allows for once-daily dosing, which is an advantage over first-generation sulfonylureas that usually require twice-daily administration due to their shorter duration of action.

**Correct Answer:**
**A.** Glyburide (glibenclamide)

**Why Each Wrong Option is Incorrect:**
1. Glimepiride (Amaryl) is a second-generation sulfonylurea drug, similar to the correct answer, making it an incorrect choice.
2. Tolbutamide (Tolecta) is a first-generation sulfonylurea drug, which is less potent and has a shorter duration of action compared to second-generation sulfonylureas like glyburide (glibenclamide).
3. Glipizide (Metaglip, Minidiab) is another second-generation sulfonylurea drug, similar to the correct answer, and therefore, an incorrect choice.

**Clinical Pearl:**
Sulfonylureas, like glyburide (glibenclamide), are commonly used as first-line oral hypoglycemic agents in the management of type